Pharmacist by training, Designer at heart, Investor with curiosity
Danny is the Head of Corporate Development at WELT, a spin-off of Samsung exploring the intersection of healthcare and technology. WELT creates personalized digital therapeutics that combine our expertise in sensor and digital biomarker technologies with therapeutic contents for the treatment of diseases with a high unmet medical need.
Outside work, Danny's a PharmD student and a Board Member of Health Sciences Entrepreneurs at Northeastern University, where he founded ViTAL (previously, Bouve Innovators), Northeastern's healthcare innovation hub.
In the past, Danny served as the Director of Business Development at Soundable Health, VP at Contrary Capital, Corporate Development Analyst with Pear Therapeutics as an operator at PillPack (PillPack's biggest fanboy—Danny's unofficial title at the company); the company was acquired by Amazon for $1B during his stay.
He's an advisor to several early-stage startups and family offices pertaining to their healthcare tech investments. Danny also invests in early-stage startups as an angel investor and as a syndicate (Notable Exit: VUNO IPO'21) Danny's a Forbes 30 Under 30 Fellow, Underscore VC’s Top Rising Star in Tech, a mentor at MIT Hacking Medicine, and a novice barista.